Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ASH 2018 /
Reduction of chemotherapy cycles for diffuse large B-cell lymphoma

1st - 4th Dec 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 01.12.18
Views: 457

Dr Viola Pöschel - Saarland University Medical School, Homburg, Germany

Dr Viola Pöschel speaks to ecancer at ASH 2018 about reducing chemotherapy cycles for diffuse large B-cell lymphoma from 6 to 4.

She describes how it was possible to maintain efficacy whilst reducing toxicity by decreasing these cycles.

Dr Pöschel describes the methods and findings in detail.

Watch her press conference here.

Read the article here.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation